A Phase I Trial of Samarium-153-Lexidronam Complex for Treatment of Clinically Nonmetastatic High-Risk Prostate Cancer: First Report of a Completed Study

Phase I Trial of Weekly Cabazitaxel with Concurrent Intensity Modulated Radiation and Androgen Deprivation Therapy for the Treatment of High-Risk Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2019.11.418 ◽

2020 ◽

Vol 106 (5) ◽

pp. 939-947

Author(s):

Jianqing Lin ◽

Robert B. Den ◽

Jacob Greenspan ◽

Timothy N. Showalter ◽

Jean H. Hoffman-Censits ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Phase I ◽

Androgen Deprivation Therapy ◽

Phase I Trial ◽

Androgen Deprivation ◽

Intensity Modulated ◽

Phase I Trial of Pelvic Nodal Dose Escalation With Hypofractionated IMRT for High-Risk Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2010.09.018 ◽

2012 ◽

Vol 82 (1) ◽

pp. 184-190 ◽

Cited By ~ 43

Author(s):

Jarrod B. Adkison ◽

Derek R. McHaffie ◽

Søren M. Bentzen ◽

Rakesh R. Patel ◽

Deepak Khuntia ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Phase I ◽

Dose Escalation ◽

Phase I Trial ◽

Phase I trial of weekly cabazitaxel with concurrent intensity modulated radiation therapy (IMRT) and androgen deprivation therapy (ADT) for the treatment of high-risk prostate cancer (PCa).

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.e16009 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. e16009-e16009

Author(s):

Jianqing Lin ◽

Robert Benjamin Den ◽

Timothy N Showalter ◽

Jean H. Hoffman-Censits ◽

Monica McGuire ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

High Risk ◽

Phase I ◽

Androgen Deprivation Therapy ◽

Phase I Trial ◽

Intensity Modulated Radiation Therapy ◽

Intensity Modulated ◽

Phase I Trial of Stereotactic Radiotherapy Prior to Robotic Prostatectomy in High Risk Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2020.07.534 ◽

2020 ◽

Vol 108 (3) ◽

pp. e908

Author(s):

C. Liveringhouse ◽

A.J. Sim ◽

K. Yamoah ◽

J. Pow-Sang ◽

P.A.S. Johnstone

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Phase I ◽

Stereotactic Radiotherapy ◽

Phase I Trial ◽

Robotic Prostatectomy ◽

A phase I/II study of acute and late physician assessed and patient-reported morbidity following whole pelvic radiation in high-risk prostate cancer patients

Acta Oncologica ◽

10.1080/0284186x.2021.1979246 ◽

2021 ◽

pp. 1-6

Author(s):

Stine E. Petersen ◽

Lise B. Thorsen ◽

Steinbjørn Hansen ◽

Peter M. Petersen ◽

Henriette Lindberg ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Phase I ◽

Cancer Patients ◽

Pelvic Radiation ◽

Patient Reported ◽

Abstract CT016: A first in man phase I/II adjuvant dendritic cell vaccine study in high-risk prostate cancer patients following radical surgery reduce the incidence of biochemical relapse

10.1158/1538-7445.am2018-ct016 ◽

2018 ◽

Author(s):

Anne Merete Tryggestad ◽

Iris Bigalke ◽

Karol Axcrona ◽

Bjørn Brennhovd ◽

T Kirsti Hønnåshagen ◽

...

Keyword(s):

Prostate Cancer ◽

Dendritic Cell ◽

High Risk ◽

Phase I ◽

Radical Surgery ◽

Dendritic Cell Vaccine ◽

Cell Vaccine ◽

Biochemical Relapse ◽

Results from a first in man Phase I/II adjuvant Dendritic Cell Vaccine study in high risk prostate cancer patients following radical surgery

Cytotherapy ◽

10.1016/j.jcyt.2017.02.025 ◽

2017 ◽

Vol 19 (5) ◽

pp. S15 ◽

Cited By ~ 1

Author(s):

A.A. Tryggestad ◽

I. Bigalke ◽

K. Axcrona ◽

E. Inderberg ◽

G. Skorstad ◽

...

Keyword(s):

Prostate Cancer ◽

Dendritic Cell ◽

High Risk ◽

Phase I ◽

Cancer Patients ◽

Radical Surgery ◽

Dendritic Cell Vaccine ◽

Cell Vaccine ◽

Final Results of a Phase I Trial of Total Androgen Blockade, Weekly Docetaxel, and Image-guided Intensity Modulated Radiotherapy for Localized High-risk Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2011.06.635 ◽

2011 ◽

Vol 81 (2) ◽

pp. S395

Author(s):

D.T. Marshall ◽

A. Golshayan ◽

A. Kraft ◽

U. Chaudhary

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Phase I Trial ◽

Intensity Modulated Radiotherapy ◽

Image Guided ◽

Weekly Docetaxel ◽

Intensity Modulated ◽

Risk Prostate Cancer ◽

Androgen Blockade

Phase I/II Study of Preoperative Radiation and Docetaxel Activity Study for High-Risk Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2011.06.625 ◽

2011 ◽

Vol 81 (2) ◽

pp. S390

Author(s):

A.Y. Hung ◽

P.E. Farris ◽

T. Beer ◽

M. Garzotto

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Phase I ◽

Preoperative Radiation ◽

105 oral Analysis of acute and late morbidity, and biochemical control for intermediate to high risk prostate cancer treated with androgen deprivation, HDR and 3D/IMRT: 4 year results of a phase I-II dose escalation trial

Radiotherapy and Oncology ◽

10.1016/s0167-8140(04)80156-7 ◽

2004 ◽

Vol 71 ◽

pp. S52-S53

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Phase I ◽

Dose Escalation ◽

Androgen Deprivation ◽

Biochemical Control ◽

Late Morbidity ◽